NurExone Biologic Inc: NurExone Biologic Secures EMA Orphan Status for ExoPTEN in Spinal Cord Injury, Accelerating Pathway to European Markets
NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) ("NurExone" or the "Company"), a biopharmaceutical company developing exosome-based ...
NurExone Biologic Secures EMA Orphan Status for ExoPTEN in Spinal Cord Injury, Accelerating Pathway to European Markets
TORONTO and HAIFA, Israel, Nov. 13, 2024 (GLOBE NEWSWIRE) -- . (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) ("NurExone" or the "Company"), a biopharmaceutical company developing exosome-based ...
Best Health on MSN14h
How I Got to the Bottom of My Sciatica Pain in My Back and Leg
The pain started in waves in my lower back and travelled down my left thigh as I worked bent over my laptop on my couch—the ...
GlobalData on MSN1d
Nevro secures CE mark for AI-based spinal cord stimulation system
US-based device company Nevro has secured market authorisation from the European Union (EU) for its HFX iQ spinal cord ...
The brain and spinal cord connection | Healthwatch 16
Newswatch 16's Kerry Kearns talked to a neurosurgeon at UPMC about the connection between the brain and spinal cord and when ...